Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Dec 03, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, offering a consistent and reliable option for managing intraocular pressure (IOP). Differing from traditional eye drops that need to be applied every day, iDose® TR is a tiny, implantable device crafted to provide a controlled dispensation of treatment directly into the eye over an extended period. This cutting-edge approach reduces the burden of constant dosing, significantly improving patient adherence and overall treatment results.

At Eye Center South, we are honored to introduce iDose® TR as part of our holistic glaucoma care. The device is implanted during a simple and low-risk procedure, designed with your ease in mind. Once in place, it provides a steady dose of the prescribed medication, keeping IOP levels consistent and safeguarding your eyesight. Patients who have difficulty managing the demands of frequent eye drop use can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South